Marsh & McLennan Companies (NYSE:MMC – Get Free Report) had its target price dropped by stock analysts at Keefe, Bruyette & Woods from $214.00 to $210.00 in a research report issued on Monday,Benzinga reports. The firm presently has an “underperform” rating on the financial services provider’s stock. Keefe, Bruyette & Woods’ price target indicates a potential downside of 3.58% from the stock’s current price.
MMC has been the subject of a number of other research reports. Royal Bank of Canada raised Marsh & McLennan Companies from a “sector perform” rating to an “outperform” rating and lifted their target price for the stock from $242.00 to $250.00 in a report on Thursday, December 12th. BMO Capital Markets lifted their target price on Marsh & McLennan Companies from $217.00 to $228.00 and gave the company a “market perform” rating in a research report on Tuesday, October 22nd. Bank of America lifted their target price on Marsh & McLennan Companies from $248.00 to $250.00 and gave the company a “neutral” rating in a research report on Thursday, October 10th. Wells Fargo & Company lifted their target price on Marsh & McLennan Companies from $212.00 to $223.00 and gave the company an “equal weight” rating in a research report on Friday. Finally, Roth Mkm boosted their price target on Marsh & McLennan Companies from $220.00 to $230.00 and gave the stock a “neutral” rating in a report on Friday, October 18th. Two analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $229.13.
Check Out Our Latest Stock Report on Marsh & McLennan Companies
Marsh & McLennan Companies Stock Performance
Marsh & McLennan Companies (NYSE:MMC – Get Free Report) last released its quarterly earnings data on Thursday, January 30th. The financial services provider reported $1.87 EPS for the quarter, topping analysts’ consensus estimates of $1.75 by $0.12. Marsh & McLennan Companies had a net margin of 16.60% and a return on equity of 32.60%. Equities research analysts forecast that Marsh & McLennan Companies will post 9.45 EPS for the current year.
Hedge Funds Weigh In On Marsh & McLennan Companies
A number of institutional investors have recently modified their holdings of the company. Parcion Private Wealth LLC raised its position in shares of Marsh & McLennan Companies by 2.0% during the fourth quarter. Parcion Private Wealth LLC now owns 25,938 shares of the financial services provider’s stock worth $5,509,000 after purchasing an additional 521 shares during the period. Concurrent Investment Advisors LLC raised its position in Marsh & McLennan Companies by 15.1% in the 4th quarter. Concurrent Investment Advisors LLC now owns 7,933 shares of the financial services provider’s stock valued at $1,685,000 after buying an additional 1,043 shares during the last quarter. Advyzon Investment Management LLC purchased a new stake in Marsh & McLennan Companies in the 4th quarter valued at $240,000. Handelsbanken Fonder AB raised its position in Marsh & McLennan Companies by 9.4% in the 4th quarter. Handelsbanken Fonder AB now owns 191,512 shares of the financial services provider’s stock valued at $40,679,000 after buying an additional 16,464 shares during the last quarter. Finally, WealthBridge Capital Management LLC raised its position in Marsh & McLennan Companies by 29.6% in the 4th quarter. WealthBridge Capital Management LLC now owns 1,442 shares of the financial services provider’s stock valued at $306,000 after buying an additional 329 shares during the last quarter. 87.99% of the stock is owned by institutional investors and hedge funds.
Marsh & McLennan Companies Company Profile
Marsh & McLennan Cos., Inc is a professional services firm, which engages in offering clients advice and solutions in risk, strategy, and people. It operates through the Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment is involved in risk management activities, as well as insurance and reinsurance broking and services.
Featured Stories
- Five stocks we like better than Marsh & McLennan Companies
- Business Services Stocks Investing
- Teva Pharma: Why This Generic Drug Giant Is a Smart Buy Now
- What Are Dividend Contenders? Investing in Dividend Contenders
- Big Dividend Hikes: 4 Large-Cap Stocks Increasing Payouts
- What Does a Stock Split Mean?
- Procter & Gamble: A Consumer Staples Titan Built to Win
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.